Search

everythinglearnresearchcommunity

for

Search:↓

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Shift nurses show altered body temperature and stress hormone levels, suggesting their body clocks adjust to irregular schedules.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

COVID-19 temporarily affects male reproductive health, but sperm and testosterone levels generally return to normal after three months.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

A systematic approach is crucial for managing hair loss in women.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Hair follicle regeneration possible, more research needed.

A blood pressure drug, diltiazem, may also help treat influenza.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Beard and scalp hair cells have different gene expressions, which may affect beard growth characteristics.

Some alternative treatments for hair loss might work, but more research is needed.

Plant-based ingredients are effective and safe for modern skincare products.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Genetic and environmental factors, like smoking and exercise, affect male hair loss.

Fadrozole and Finasteride change frog sex ratios and cause intersex animals with altered gene expressions.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.